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ABSTRACT 
Objectives:  To quantify how incremental capillary perfusion loss, such as that seen in 
experimental models of sepsis, affects tissue oxygenation using a computation model of 
oxygen transport.  
Methods:  A computational model was applied to capillary networks with dimensions 
84x168x342 (NI) and 70x157x268 (NII) μm, reconstructed in vivo from rat skeletal muscle.  
Functional capillary density (FCD) loss was applied incrementally up to ~40% and 
combined with high tissue oxygen consumption to simulate severe sepsis. 
Results:  A loss of ~40% FCD loss decreased median tissue PO2 to 22.9 and 20.1 mmHg in 
NI and NII compared to 28.1 and 27.5 mmHg under resting conditions.  Increasing red blood 
cell supply rate (SR) to baseline levels returned tissue PO2 to within 5% of baseline.  High 
consumption combined with a 40% FCD loss, resulted in tissue anoxia in both network 
volumes and median tissue PO2 of 11.5 and 8.9 mmHg in NI and NII respectively; median 
tissue PO2 was recovered to baseline levels by increasing total SR 3 – 4 fold.   
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Conclusions:  These results suggest a substantial increase in total SR is required in order to 
compensate for impaired oxygen delivery as a result of loss of capillary perfusion and 
increased oxygen consumption during sepsis. 
 
KEYWORDS  
sepsis; oxygen delivery; functional capillary density; blood flow; oxygen transport 
 
ABBREVIATIONS USED 
3D, three-dimensional; EDL, extensor digitorum longus; FCD, functional capillary density; 
NI, network I; NII, network II; PO2, partial pressure of oxygen; RBC, red blood cell; SO2, 
oxygen saturation; SR, supply rate;  
 
INTRODUCTION 
Mortality from sepsis and septic shock remains high despite improved diagnosis using 
biomarkers [21] and implementation of goal directed therapy [22,24,25].  Sepsis has been 
defined as a systemic inflammatory response to a bacterial infection [4] and is a common 
cause of mortality in a range of patient groups.  Observable changes to blood flow within the 
microcirculation have been identified clinically within hours of infection onset [29].  
Dysfunctional microvascular blood flow has been identified in animal models as a 
characteristic associated with the systemic inflammation in experimental sepsis; the most 
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notable aspect of blood flow disruption in these models is the loss of capillary perfusion in 
tissue remote to the site of infection [2,20].  The loss of perfused capillaries in the 
microvasculature impairs oxygen delivery and is followed by deleterious effects caused by 
hypoxia in living tissue [6].  Inadequate oxygen delivery in sepsis has therefore been 
hypothesized as a factor contributing to multiorgan dysfunction and patient mortality and 
as such has received considerable attention from researchers and clinicians. 
 
Experimental models have shown varying degrees of perfusion loss in skeletal 
muscle, liver, brain and intestinal microcirculation [1,6,27,28].  The challenge of making 
direct measurements of tissue oxygen in vivo has led to the use of computer models in order 
to quantify how loss of capillary perfusion impacts oxygen delivery to living tissue.  
Previous modeling efforts by Goldman et al. utilized generated parallel capillary arrays and 
experimental measurements to provide a detailed description of oxygen tension within 
three-dimensional tissue volumes with loss of functional capillary density consistent with 
that observed in the skeletal muscle of a rat peritonitis model [12,13].  By adjusting tissue 
consumption in the model Goldman et al. matched observed oxygen extraction ratios from 
skeletal muscle capillaries.  Goldman et al. concluded that increased consumption as 
predicted by the model and decreased oxygen supply would make tissue more susceptible 
to hypoxia in sepsis [13]. 
In a previous study we demonstrated that computer models using equivalent parallel 
capillary arrays result in higher estimates of tissue PO2 when compared to capillary 
geometries reconstructed from intravital video recordings of blood flow in vivo [10].  The 
discrepancy between calculated tissue PO2 in parallel arrays and reconstructed network 
geometries was shown under normal conditions as well as under simulated exercise, 
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ischemia and hypoxia.  We concluded that real network geometries reconstructed from 
experimental observations, produced oxygen transport solutions that more accurately 
represent the spatial PO2 distribution and mean PO2 values in vivo compared to equivalent 
parallel arrays generated using average measurements from the same experimental data 
sets.  Given this result, computational models should utilize reconstructed or realistic 
network geometries, and corresponding experimental measurements of velocity, 
hematocrit and oxygen (SO2 or PO2) whenever possible. 
 
In the present study we examine the impact of progressive functional capillary 
perfusion loss on oxygen transport in 3D reconstructed capillary networks.  The impact of 
incremental FCD loss on oxygen delivery in vivo is not known, though computer models 
utilizing parallel arrays have shown decreased tissue PO2 as a result of FCD loss [12,13].  By 
utilizing reconstructed networks we are able to simulate septic flow dysfunction in real 
capillary networks.  Application of a physical flow model was used to determine blood flow 
redistribution resulting from stoppages in individual capillary segments.  We then 
compared the resulting oxygen transport changes to solutions produced using baseline red 
blood cell supply rate produced from direct vessel-by-vessel hemodynamic and oxygen 
measurements made from the sample networks in vivo.   
 
Recent clinical studies have monitored venous O2 saturation in septic patients and 
used this metric as a target measurement for early goal directed therapies.  Central venous 
SO2 has been used as a trigger for blood transfusion and has been shown to improve 
through fluid resuscitation [22,24,26].  In the current study we were able to quantify how 
increasing red blood cell supply rate affects venular outflow saturation (SvO2) from discrete 
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capillary networks.  The relationship between SvO2 and restoration of basal tissue PO2 
levels can be related to clinical measurements of mixed venous saturation as a target for 
treatment of septic patients. 
The objective of the present study is to quantify how varying degrees of FCD loss affect 
tissue oxygenation.  Furthermore we aim to determine if increasing blood flow to hypoxic 
tissue will ameliorate oxygen delivery in the presence of increased oxygen consumption, a 
condition observed in experimental models of sepsis.  Understanding how oxygen delivery 
is impaired in this model and how increased blood supply affects tissue oxygenation 
provides support to the concept of early goal directed therapy. 
 
MATERIALS AND METHODS 
3D Network Reconstruction 
Two capillary networks from intravital microscopy of rat extensor digitorum longus 
muscle [20] that were reconstructed for a previous study [9], were used in blood flow and 
oxygen transport simulations; the methods of which have been described previously [9,30].  
Briefly, video sequences of microvascular flow were processed to create functional images 
and overlapping fields of view and focal planes were registered to produce a mosaic map of 
the volume of interest.  Characteristic features in each image were used for registration 
allowing for vessels to be tracked between images and focal planes.  Vessels in each image 
were segmented using both manual and automated methods.  Connections between vessel 
segments and at bifurcations were created using automated algorithms creating contiguous 
maps of network geometries.  Completed geometries were processed with quality control 
software to ensure contiguous geometry, and appropriate proper flow directions as 
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observed in vivo.  Resulting vascular maps provide an accurate representation of the 
structure and transport conditions observed experimentally (as detailed below) in two 
discrete network volumes (see Table 1 for a summary of the network geometric data). 
 
Capillary Hemodynamic and Oxygen Saturation Measurements 
 
Individual vessels within each network geometry were analyzed to measure 
hematocrit, cell velocity and oxygen saturation using custom software package similar to 
that described previously [3,11,18].  Vessel segments were selected from functional images 
of microvascular flow [17] and space-time images [8] were created from 60 second long 
video sequences.  Space-time images were used to measure cell velocity, hematocrit, and 
oxygen saturation using dual wavelength absorption spectroscopy [7,19].  Mean values 
measured for each vessel were indexed to the network geometry such that recorded data 
measured in vivo was paired with the specific capillary within the 3D geometry. 
 
Modeling Flow in 3D Capillary Networks 
Network reconstructions were processed to create a node-to-node description of 
the geometry for use in a steady state flow model [9].  Velocity and hematocrit values  not 
measured experimentally were calculated using a mass balance to determine supply rate in 
parent and daughter vessels; this process was repeated in upstream segments as necessary 
to determine inflow node velocity, hematocrit, and supply rate.  An existing steady state 
flow model [14] was applied using the flow equations described by Pries et al [23].  Inlet 
and outlet pressures were adjusted to approximate the specific velocity distribution 
A
cc
ep
te
d 
A
rt
ic
le
 
This article is protected by copyright. All rights reserved. 
observed in vivo and to create a starting point for further scaling of the flow model.  RBC 
supply rates were recorded from the in vivo data in a cross section of the network and the 
total network RBC supply rate was determined.  The pressure boundary conditions were 
incrementally adjusted until the RBC supply rate matched the experimentally measured 
values within < 0.1% [9].   
 
In order to simulate the loss of functional capillary density (FCD) observed in the 
experimental models of sepsis, a subset of vessels were set to be stopped for a given 
perfusion loss using the following approach.  Individual stop flow capillaries were randomly 
selected from the group of vessels within the network that intersected in projection with 
two sampling lines perpendicular to the network volume Y axis (Figure 1).   Blood flow was 
arrested in the target vessels by increasing intra-capillary resistance such that the resulting 
flow solution calculated supply rate to be < 10-4 of the original values in each of the target 
stop flow capillaries.  Percent of FCD loss was calculated by counting the number of stopped 
flow vessels divided by the total number of vessels that intersected each sample line.  Levels 
of FCD loss were created to approximately correspond to 10%, 20%, 30% and 40% FCD 
loss. The original pressure drop across the networks in the incremental perfusion loss 
simulations were held constant resulting in decreased supply rate with increasing FCD loss 
(Table 2 and 3).  Longitudinal capillary point density for all levels of FCD loss, calculated as 
described previously[10], are shown in Figure 2.  Flow solutions were created as described 
previously for each network at four levels of FCD loss; the ~40% range of FCD loss at 1X, 2X, 
3.5X and 4X baseline RBC supply rates; and control simulations by iteratively adjusting 
inflow pressures until the target supply rate in inflow vessels was reached [9].  A single 
counter current inlet vessel in Network II was held constant at the originally measured RBC 
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supply rate for all network II simulations.  Control conditions with 0% FCD loss and supply 
rate matched to the incremental perfusion loss cases, and high consumption cases at 1X, 2X, 
3.5X, and 4X supply rate were generated and separate simulations were run as a 
comparison for the cases with FCD loss. 
 
Oxygen Transport Model 
Oxygen tension in tissue was calculated using a finite difference model of oxygen transport 
developed by Goldman and Popel [14] and described previously [9].  Flow solutions 
generated for each case described above were used as the input for the transport models in 
order to describe tissue PO2 within the sample volumes under each simulated condition.  
Finite elements were defined for the entire volume resulting in a monotonic 2 μm grid 
spacing. The diffusion between individual volume elements was calculated at each time step 
yielding PO2 for each volume element, P(x,y,z,t), as follows: [9,14].   
 ∂P
∂t
= 1+ cMb
α
dSMb
dP




−1
D∇2P − 1
α
M P( ) + 1
α
DMbcMb∇ ⋅
dSMb
dP
∇P



  (1) 
where D, α, and M(P) are the diffusion coefficient, solubility and consumption rate of O2 
respectively of the tissue.  Myoglobin concentration (cMb), diffusivity (DMb), and saturation 
(SMb) are also addressed through Equation 1 where SMb is determined by SMb(P) = P / (P + 
P50,Mb) where SMb(P) is the myoglobin saturation at a given partial pressure and P50,Mb is the 
partial pressure at which  myoglobin is 50% saturated.  Oxygen levels in the blood were 
determined within each vessel at each axial location (ξ) using a convective mass balance 
equation that describes blood oxygen saturation S(ξ,t): 
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  (2) 
where u is the mean blood velocity, R is capillary radius, j is the oxygen flux out of the 
capillary at the axial location (ξ,θ), C is the O2-binding capacity of blood, Pb is the 
intracapillary PO2 and αb is the solubility of O2 in plasma. 
The flux of O2 between capillaries and tissue is was defined as: 
 j = κ Pb − Pw( )  (3) 
where κ is the mass transfer coefficient and Pw is the tissue PO2 at the capillary surface. κ is 
a function of the capillary hematocrit in a given vessel and reflects the effect of red blood 
cell spacing on diffusional exchange between capillary and tissue [5]. The boundary 
condition at the capillary-tissue interface was specified as: 
 −Dα ∂Pw
∂n
= j  (4) 
where n is the unit vector normal to the capillary surface and j is defined by Eq. 3.  
Boundary conditions at the tissue edges were specified as a zero flux boundary condition. 
The above O2 transport equations 1 – 4 were combined with Michaelis-Menten 
consumption kinetics, M = M0 P/(P + Pcr) and the Hill equation for oxyhemoglobin 
saturation, S(P) = Pn/( Pn + P50n) to define O2 transport within the 3D volume [15].  The 
baseline oxygen consumption rate, M0, (Table 2 & 3) was selected such that the resulting 
capillary SO2 throughout the network fit approximately with experimental observations.  
Simulations were ran from a starting state of zero PO2 throughout the volume and diffusion 
was calculated between capillaries and tissue elements incorporating consumption for each 
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case as described in Table 2 and 3.  Values for constants used in the equations above are 
listed in Table 4.  Each simulation was run to a steady state condition established when the 
slope of tissue PO2 over time in corner elements was equal to zero.   
 
RESULTS 
Steady state oxygen transport simulations were completed, for each reconstructed 
network geometry, under four incremental levels of functional capillary density loss with 
normal oxygen consumption conditions.  Tissue PO2 distributions calculated for each case 
under normal consumption are shown in Figure 3.  Increasing FCD loss and a concomitant 
decrease in RBC supply rate resulted in a progressive reduction in median tissue PO2 levels 
from baseline values of 28.1 mmHg and 27.5 mmHg for networks I and II respectively.  At 
the highest level of FCD loss (40% for network I and 42.9% for network II) median tissue 
PO2 was reduced to 22.9 mmHg, in network I, and 20.1 mmHg in network II.  In both 
network geometries the highest level of FCD loss caused the span of the fourth quartile of 
PO2 values to widen and tissue PO2 values residing in the third quartile to fall below the 
median value at baseline (Figure 3).  When boundary pressures were increased to restore 
RBC supply rate to baseline levels for 40.0% and 42.9% FCD loss, median tissue PO2 
increased to 26.7 mmHg in network I and 26.8 mmHg in network II; returning median PO2 
to within 5% of baseline levels. 
Color PO2 surface maps in Figure 5 illustrate PO2 conditions with normal consumption in 
the network I sample volume under baseline and the resulting drop in PO2 following a 40% 
FCD loss denoted in vessel maps by gray shaded segments.  A substantial shift in the lower 
quartile was seen for both sample network volumes dropping from 23.8 and 25.0 mmHg 
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under baseline conditions with normal consumption to 17.2 and 17.4 mmHg with a 40% 
FCD loss.  The decrease in the lower quartile tissue PO2 values for network I are clearly 
visualized in Figure 5 showing the fall of tissue PO2 levels at the venous end of the network 
following the imposed perfusion loss and associated flow redistribution.  Minimum tissue 
PO2 fell to 13.5 and 15.4 mmHg compared to the baseline levels of 19.5 and 22.4 mmHg in 
networks I and II respectively.  The lower left panel of Figure 5 shows the tissue PO2 of 
network I with 40% FCD loss following RBC supply rates being restored to baseline.  The 
lower quartile values for networks I and II with 40.0% and 42.9% FCD loss and restoration 
of baseline RBC supply rate increased tissue PO2 to 22.04 and 24.5 mmHg, while minimum 
tissue PO2 similarly increased to 18.9 and 22.5 mmHg respectively.   
 
Mixed capillary outflow saturation (SvO2) decreased progressively with increasing FCD loss.  
By imposing a 40.0% and 42.9% FCD loss the corresponding drop in RBC supply rate caused 
SvO2to drop to 12.9 and 13.2 percent saturated compared to 23.8 and 26.9 percent 
saturated under baseline conditions.  With baseline RBC supply rate restored in network I 
at 40.0% FCD loss and network II at 42.9% FCD loss, SvO2 increased to 23.5 and 27.4 
percent saturation in the two networks respectively.   
 
A second set of steady state oxygen transport simulations were completed, for each 
network volume, with the highest level of FCD loss (40.0% and 42.9%) and double the 
baseline oxygen consumption, at incrementally increasing RBC supply rates (Figure 4).  
Median tissue PO2 levels for double oxygen consumption and baseline RBC supply rate was 
11.5 mmHg for network I and 8.9 mmHg for network II.  The lower quartile for baseline RBC 
supply rate lay at 2.7 and 3.3 mmHg with simulations resulting in minimum PO2 of 0.0 and 
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0.4 mmHg for network I and II respectively.  A doubling of the baseline RBC supply rate was 
not sufficient to restore median tissue PO2 levels in either network with the median rising to 
20.6 and 22.6, lower quartiles of 11.7 and 19.7, and minimum tissue PO2 of 9.8 and 15.0 
mmHg in networks I and II respectively.  A 3.5 fold increase in RBC supply rate restored 
median tissue PO2 in network II (27.9 mmHg) whereas a 4-fold increase was necessary to 
restore baseline levels in network I (28.0 mmHg).  Increasing RBC supply rate resulted in 
distinctly narrowed PO2 distributions in each network volume, particularly in the second 
and third quartiles. 
 
With doubled oxygen consumption rate and baseline RBC supply rate the SvO2 fell to 
0.0 and 0.4 percent saturation in networks I and II.  Doubling RBC supply rate dramatically 
increased SvO2 in both networks, restoring outflow saturations to 16.9 and 23.5 percent 
saturation in networks I and II respectively.  Higher RBC supply rates resulted in SvO2 well 
above baseline levels.  The 3.5 fold increase in RBC supply rate caused SvO2 of 34.5 percent 
saturation in network I and 38.6 percent saturation in network II, while 4 times baseline 
supply rate raised outflow saturations to 44.4 and 41.3 percent saturation in the two 
networks respectively. 
Pressures needed to create RBC flux conditions in each simulation are shown in Table 2 and 
3 for networks I and II respectively.  Under baseline boundary pressures increasing 
perfusion loss (PL) resulted in decreased RBC supply rate in each network though supply 
rate decreases were dependent on individual vessels that were caused to stop and therefore 
did not create linear decreases in supply rate with increasing FCD loss.  In order to increase 
RBC supply rate in the high consumption (HC) simulations it was necessary to increase 
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boundary pressures such that the mean pressure drop increased by a factor larger than the 
scale of desired RBC supply rate increase.  
 
DISCUSSION 
Using real microvascular geometry, and associated experimental intravital 
microscopic measurements from rat extensor digitorum longus, we have shown how FCD 
loss with a concomitant decrease in RBC supply rate would impact tissue oxygenation.  
Further we have demonstrated that restoration of baseline RBC supply rate will restore 
original tissue PO2 levels and that in order to compensate for increased metabolic 
consumption with FCD loss, it is necessary for blood flow to increase several fold.  With 
normal consumption, the highest tested FCD loss caused up to a 27% decrease in median 
tissue PO2 and a 31% decrease in minimum PO2.  By increasing the total RBC supply rate to 
the simulated tissue volume under normal consumption conditions and the highest level of 
FCD loss, median tissue PO2 was restored to within < 5% below baseline, and minimum 
tissue PO2 was returned to within 3% of baseline in network I.  In network II, restoration of 
baseline RBC SR caused median tissue PO2 to be increased to within 1% of baseline.  Control 
simulations with no stopped vessels and RBC supply rates matched to the incremental FCD 
loss simulations showed decrease in tissue PO2 comparable to the corresponding level of 
FCD loss; this suggests that in the absence of high consumption the decreased PO2 was 
primarily due to impaired supply resulting from stopped flow vessels and not from higher 
diffusion distance to flowing capillaries.  Furthermore, the presence of anastamoses 
between adjacent capillaries allow for blood flow to redistribute around stopped flow 
vessels limiting the impact a heterogeneous stoppage of capillaries may have on oxygen 
delivery. 
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Increased oxygen consumption in the presence of high FCD loss with baseline flow 
conditions caused a radical drop in tissue PO2 creating anoxic regions in sample networks 
(Figure 4 & 6) and resulting in substantial hypoxia throughout the tissue volumes while 
reducing median tissue PO2 to 41% (network I) and 32% (network II) of baseline levels.  
Under these conditions 26% of tissue elements in network I and 14% in network II had PO2 
levels below 3 mmHg.  Cellular metabolism has been previously shown to decreases under 
hypoxic conditions in an oxygen dependent fashion when PO2 drops below 2 mmHg [31].  
However recent work by Wilson in isolated mitochondria [32] and Golub in skeletal muscle 
[16] found critical PO2 (the partial pressure resulting in half maximal respiration) to be 
between 10 – 12 mmHg.  By doubling RBC supply rate, tissue PO2 was partially recovered in 
simulations for both network volumes, restoring tissue oxygen levels to 73% and 82% of 
baseline in networks I and II respectively and no tissue elements with PO2 below 10 mmHg.  
In order to return median tissue PO2 back to baseline under high consumption and high FCD 
loss conditions it was necessary to increase RBC supply rate by 4 fold in network I resulting 
in a tissue PO2 99.6% of baseline while an increase of 3.5 fold was necessary in network II to 
restore median tissue PO2 to 101% of baseline levels.  This clearly illustrates that a 
substantial increase in RBC flux is necessary to compensate for the combination of observed 
FCD loss and the estimated high consumption present in microvascular septic injury.  
Control simulations that matched increases in RBC supply rates in the absence of FCD loss 
showed that a substantial proportion of the depressed tissue PO2 was a result of increased 
diffusion distance in the ~40% FCD loss simulations indicating that perfusion loss 
combined with high consumption results in both a supply and diffusion limitation.  The 
pressure increases required to raise supply rate supply rate in the high consumption 
simulations was 25 – 34% higher in the ~40% FCD loss cases than in controls (Table 2 and 
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3).  This illustrates that meeting supply rate demands in the face of a large number of 
stopped flow vessels would require unusually high driving pressure. 
In addition to tissue PO2 we examined mixed capillary outflow saturations in each of 
the presented simulation cases. We found that progressive functional capillary density loss 
caused mixed capillary outflow saturation to decrease up to 50% compared to baseline.  
Decreases in mixed capillary outflow saturation can be compared with clinical findings that 
show a drop in mixed venous saturation in patients with severe sepsis which has also 
proven to be an indicator of higher patient mortality [25].  In the simulation cases where 
high consumption was used to simulate severe sepsis we found that increasing RBC supply 
rate by a factor of 2 restored median tissue PO2 to within 18% - 27% below baseline and 
this was reflected in a similar recovery of SvO2 to 14% - 29% below baseline values.  
However it is important to note that the blood flow increases needed to restore median 
tissue PO2 to baseline levels increased SvO2 to 40% - 87% higher than baseline levels.   
 
Previously. Goldman et al. [12] utilized parallel capillary arrays to examine the effect 
of perfusion loss in sepsis and found that tissue PO2 decreased in simulated average sepsis 
(tissue consumption Mo = 3.86E-4 mL O2/mL/s) to a mean value of 35.4 mmHg from 43.0 
mmHg in control cases.  Our findings show a PO2 of 10.3 – 11.5 mmHg in high 
consumption/high perfusion loss simulations versus 28.1 – 28.2 mmHg at baseline.  There 
are two main reasons for the differences in mean tissue PO2 determined in this study 
compared to previous findings.  First, Goldman et al. utilized an inlet blood saturation of 
69%, which is slightly higher than our experimentally measured value of 63% for the 
specific networks used in our simulations.  Higher inlet saturation would result in slightly 
elevated tissue PO2 than what our simulations predict.  Second, the relative capillary density 
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determined for the real networks used in the current study were 665 cap/mm2 and 855 
cap/mm2 compared to the density chosen by Goldman et al. of 1000 cap/mm2 and 1500 
cap/mm2.  The high vascular density, blood velocities and hematocrit used to determine 
blood flow in the previous study result in much higher RBC supply rates than those used as 
the input for our simulations.  Examination of our results in conjunction of Goldman’s 
parallel arrays allows for a greater context of the delivery of oxygen in vivo in regions of 
varying vascularization and metabolic demand.  
 
The modeling approach that we have outlined in the current work is a strong 
foundation for future efforts in studying the impact sepsis has on oxygen delivery as a result 
of microvascular injury and flow dysfunction.  This approach provides a clearer picture of 
how perfusion loss and changes to metabolism affect tissue oxygenation, and the extent to 
which hypoxia may be present in tissue during a septic insult.  Future improvements to the 
model will require precise maps of vascular geometry combined with direct measurements 
of individual vessels within the same geometry from septic animals in vivo.  Previously 
outlined strategies for applying blood flow models to sparse hemodynamic data sets[9] 
combined with tracking the specific perfusion loss within a given geometry will provide a 
further context the current study is unable to provide.  The current work represents the 
most realistic simulations that can be achieved without tracking loss of perfusion on a 
vessel-by-vessel basis, which would be the next step to fully characterize the impact of 
perfusion loss in vivo.   
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CONCLUSION   
We have described a comprehensive and detailed model of oxygen transport that 
utilizes capillary networks reconstructed from intravital videos of rat skeletal muscle 
combined with a flow model that allows hemodynamic and oxygen saturation 
measurements to accurately represent conditions measured in the network in vivo.  This 
model of oxygen transport simulates the blood flow dysfunction observed in skeletal muscle 
during experimental sepsis and reproduces varying degrees of functional capillary density 
loss, increases in tissue oxygen consumption, and recovery of the tissue by increasing red 
blood cell supply rate.  Further, we have related how capillary outflow saturation changes 
as a result of loss of perfusion and increased consumption.  Our findings provide insight into 
how tissue oxygenation may be affected by flow dysfunction in sepsis and that tissue 
hypoxemic conditions caused by a loss of vessel perfusion can be recovered by increasing 
total tissue perfusion to simulation volumes.  
 
PERSPECTIVE 
The functional impact of capillary perfusion loss in human disease is still difficult to 
characterize.  Examination of this problem in models of skeletal muscle provides a 
meaningful analog to conditions in vital organs that is important in and of itself given the 
physiological importance of skeletal muscle and the relative tissue mass that is potentially 
affected.  While predictions for mixed capillary outflow saturation do not translate directly 
to central venous measurements made in patients, it does provide a tangible reference point 
that puts into context how changing vascular density, PO2, and consumption in small 
vascular volumes might impact global measurements.  While this work does elucidate how 
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loss of perfused capillaries would impact tissue PO2, the next step is to repeat our approach 
using data collected directly from septic animals, tracking the specific vessel loss, and 
directly calculating changes in consumption within observed discrete volumes.  Collection 
of such a detailed data set, particularly from diseased animals, will remain a challenge.  This 
will be a critical step in order to move this work forward and serves as strong motivation to 
carry out 3D reconstructions and modeling directly from an animal model of sepsis.  
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Table 1:  Summary of network geometry parameters. 
Statistical summary of network geometry data. 
 Tissue Volume 
Dimensions 
(µm x µm x µm) 
Number of 
Vessel 
Segments 
Mean Capillary 
Segment 
Length 
(μm) 
Capillary 
Length Density 
(mm x mm3) 
Network I 84 x 168 x 342 25 107.4 ± 82.7 554.2 
Network II 70 x 157 x 268 20 100.9 ± 74.7 684.8 
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Table 2. Variables for Network II simulations outlining the four different levels of perfusion 
loss; high consumption simulations are indicated with associated increasing levels of RBC 
supply rate ranging from baseline RBC supply rate to 4X times baseline RBC flux. 
Network I 
Simulations 
% 
FCD 
Loss 
Consumption - 
M0 
(mL O2/mL 
tissue/s) 
RBC Supply Rate 
(mL RBC/mL 
tissue/s) 
Mean Pressure 
Drop 
(mmHg) 
Baseline 0 1.5E-4 8.25E-04 3.00 
6.7% FCD Loss 6.7 1.5E-4 7.67E-04 3.00 
Control, SR Matched to 6.7% FCD Loss 0 1.5E-4 7.67E-04 2.80 
20% FCD Loss 20 1.5E-4 7.43E-04 3.00 
Control, SR Matched to 20% FCD Loss 0 1.5E-4 7.43E-04 2.71 
26.7 FCD Loss 26.7 1.5E-4 6.83E-04 3.00 
Control, SR Matched to 26.7% FCD Loss 0 1.5E-4 6.83E-04 2.50 
40% FCD Loss 40 1.5E-4 6.07E-04 3.00 
Control, SR Matched to 40% FCD Loss 0 1.5E-4 6.07E-04 2.23 
40% FCD Loss, Baseline SR 40 1.5E-4 8.25E-04 4.03 
40% FCD Loss, High Consumption, 
Baseline SR 
40 3.0E-4 8.25E-04 4.03 
Control, 0% FCD Loss, High 
Consumption, Baseline SR 
0 3.0E-4 8.25E-04 3.00 
40% FCD Loss, High Consumption, 2X 
SR 
40 3.0E-4 1.65E-03 7.93 
Control, 0% FCD Loss, High 
Consumption, 2X SR 
0 3.0E-4 1.65E-03 5.92 
40% FCD Loss, High Consumption, 3.5X 
SR 
40 3.0E-4 2.89E-03 13.74 
Control, 0% FCD Loss, High 
Consumption, 3.5 SR 
0 3.0E-4 2.89E-03 10.29 
40% FCD Loss, High Consumption, 4X 40 3.0E-4 3.30E-03 15.69 
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SR 
Control, 0% FCD Loss, High 
Consumption, 4X SR 
0 3.0E-4 3.30E-03 11.75 
 
 
Table 3. Variables for Network II simulations outlining the four different levels of perfusion 
loss; high consumption simulations are indicated with associated increasing levels of RBC 
supply rate ranging from baseline RBC supply rate to 4X times baseline RBC flux. 
Network II 
Simulations 
% 
FCD 
Loss 
Consumption - 
M0 
(mL O2/mL 
tissue/s) 
RBC Supply Rate 
(mL RBC/mL 
tissue/s) 
Mean Pressure 
Drop 
(mmHg) 
Baseline 0 1.5E-4 6.84E-04 1.98 
7.1% FCD Loss 7.1 1.5E-4 6.62E-04 1.98 
Control, SR Matched to 7.1% FCD Loss 0 1.5E-4 6.62E-04 1.92 
21.4% FCD Loss 21.4 1.5E-4 6.12E-04 1.98 
Control, SR Matched to 21.4% FCD 
Loss 
0 1.5E-4 6.12E-04 1.78 
28.6 FCD Loss 28.6 1.5E-4 5.91E-04 1.98 
Control, SR Matched to 28.6% FCD 
Loss 
0 1.5E-4 5.91E-04 1.72 
42.9% FCD Loss 42.9 1.5E-4 4.37E-04 1.98 
Control, SR Matched to 42.9% FCD 
Loss 
0 1.5E-4 4.37E-04 1.30 
42.9% FCD Loss, Baseline SR 42.9 1.5E-4 6.84E-04 2.96 
42.9% FCD Loss, High Consumption, 
Baseline SR 
42.9 3.0E-4 6.84E-04 2.96 
Control, 0% FCD Loss, High 
Consumption, Baseline SR 
0 3.0E-4 6.84E-04 1.98 
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42.9% FCD Loss, High Consumption, 
2X SR 
42.9 3.0E-4 1.37E-03 5.70 
Control, 0% FCD Loss, High 
Consumption, 2X SR 
0 3.0E-4 1.37E-03 3.88 
42.9% FCD Loss, High Consumption, 
3.5X SR 
42.9 3.0E-4 2.39E-03 8.41 
Control, 0% FCD Loss, High 
Consumption, 3.5 SR 
0 3.0E-4 2.39E-03 6.72 
42.9% FCD Loss, High Consumption, 
4X SR 
42.9 3.0E-4 2.74E-03 11.13 
Control, 0% FCD Loss, High 
Consumption, 4X SR 
0 3.0E-4 2.74E-03 7.67 
 
 
Table 4.  List of constants and values used in oxygen transport simulations. 
Constant Value 
α 3.89 E-5  ml O2 ml-1 mmHg-1 
αb 2.82 E-5  ml O2 ml-1 mmHg-1 
C 0.52 ml O2 ml-1 
D 2.41 E-5  cm2 s-1 
Pcr 0.5  mmHg 
cMb 1.02 E-2  ml O2 ml-1 
DMb 3 E-7  cm2 s-1 
P50 37  mmHg 
P50,Mb 5.3  mmHg 
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